First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis

Company Overview

Key Stats

• Today's Range: $20.23 to $21.84
• 50-Day Range: N/A
• 52-Week Range: $14.79 to $26.80
• Volume: 13,364 shs
• Average Volume: 374,926 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $39.43
• Consensus Rating: Buy

TRAX Stock Analysis - Frequently Asked Questions

How have TRAX shares performed this year?

First Tracks Biotherapeutics' stock was trading at $17.00 on January 1st, 2026. Since then, TRAX shares have increased by 22.1% and is now trading at $20.75.

How do I buy shares of First Tracks Biotherapeutics?

Shares of TRAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: NASDAQ:TRAX
• CIK: 2091349
• Web: N/A
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for First Tracks Biotherapeutics: $39.43
• High Price Target: $54.00
• Low Price Target: $30.00
• Potential Upside/Downside: +82.6%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A